"Cellceutix will be meeting with the FDA in December to discuss advancing the clinical development of Brilacidin for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) AND Prurisol for treatment of psoriasis."
I haven't seen where they said Friday... They have said that they are meeting with the AIBDC&C Foundation stated below from the 4th through the 6th, being Thursday through Sat.
"Cellceutix management will be meeting with key opinion leaders at the 2014 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference on December 4-6, 2014 in Orlando, Florida."
Maybe they will split up to cover the two? Not sure, but you'd think they will all want to be at the FDA meeting, being how important it is. I'd guess that the FDA mtg is sometime the next two weeks.